ConductScience.org, home

Paper41999136

Molecular cancer prevention: Intercepting disease.

Grieco C and 2 others. Mol Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Molecular cancer prevention: Intercepting disease. Papers, record 41999136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular cancer prevention: Intercepting disease.
PubMed
Journal
Mol Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grieco CCharlottehttps://orcid.org/0000-0003-3177-7245
2Pandya TTejhttps://orcid.org/0000-0002-1816-1211
3Swanton CCharleshttps://orcid.org/0000-0002-4299-3018

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Humans
Animals
Biomarkers, Tumor
Clinical Trials as Topic

Grants20

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CC2041Wellcome TrustUnited KingdomPubMed
BCRF-23-157Breast Cancer Research FoundationPubMed
UCL Experimental Cancer Medicine CentrePubMed
C11496/A30025CRUK Lung Cancer Centre of ExcellencePubMed
ID16584Novo NordiskPubMed
ASPIRE Phase II award (23-034-ASP)Mark Foundation For Cancer ResearchPubMed
Research Aspire Award (21-029-ASP)Mark Foundation For Cancer ResearchPubMed
Napier Research Professor RSRP\R\210001Royal SocietyPubMed
Professorship Enhancement Award RF\ERE\231118Royal SocietyPubMed
RP/EA/180007Royal SocietyPubMed
Doctoral Training in AI-enabled HealthcareUK Research and InnovationPubMed
Studentship EP/S021612/1UK Research and InnovationPubMed
Rosetrees TrustPubMed
University College London Hospitals Biomedical Research CentrePubMed
ERC Advanced (PROTEUS) 835297HORIZON EUROPE European Research CouncilPubMed
CC2041Wellcome TrustUnited KingdomPubMed
CRUK CoL CRTF (SEBCATP-2024/100003)Cancer Research UKUnited KingdomPubMed
EDDPMA-Nov21/100034Cancer Research UKUnited KingdomPubMed
PEACE (C416/A21999)Cancer Research UKUnited KingdomPubMed
TRACERx (C11496/A17786)Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132025013The evolutionary history of 2,658 cancers.Nature2020https://conductscience.org/library/papers/32025013PubMed
232744862Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.Ann Intern Med2020https://conductscience.org/library/papers/32744862PubMed
35279523Mutation and cancer: statistical study of retinoblastoma.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5279523PubMed
440619604Precision Prevention Studies: A Targeted Approach to Cancer Prevention.Cancer Prev Res (Phila)2025https://conductscience.org/library/papers/40619604PubMed
537264016The blood proteome of imminent lung cancer diagnosis.Nat Commun2023https://conductscience.org/library/papers/37264016PubMed
625826379UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.PLoS Med2015https://conductscience.org/library/papers/25826379PubMed
837059064Impact of risk factors on early cancer evolution.Cell2023https://conductscience.org/library/papers/37059064PubMed
928855077Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.Lancet2017https://conductscience.org/library/papers/28855077PubMed
1038572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1132989322The mutational signature profile of known and suspected human carcinogens in mice.Nat Genet2020https://conductscience.org/library/papers/32989322PubMed
1238571414Advancing Cancer Interception.Cancer Discov2024https://conductscience.org/library/papers/38571414PubMed
1338970563Alternative endpoints to mortality in cancer screening trials.Mol Oncol2024https://conductscience.org/library/papers/38970563PubMed
1437020004Lung adenocarcinoma promotion by air pollutants.Nature2023https://conductscience.org/library/papers/37020004PubMed
1523060474Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?J Med Screen2012https://conductscience.org/library/papers/23060474PubMed
1639193459Lung cancer screening: where do we stand?Breathe (Sheff)2024https://conductscience.org/library/papers/39193459PubMed
1737788412Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial.J Clin Oncol2024https://conductscience.org/library/papers/37788412PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42842193Precision Cancer Prevention - Research Promise and Education Needs.J Cancer Educ2026https://conductscience.org/library/papers/42842193

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41999136

GET https://conductscience.org/api/papers/v1/41999136/authors